All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Subhasis Chatterjee, MD
Disclosure(s): Eagle Pharmaceutcials: Advisory Board (Terminated, March 10, 2022)

Alison Ward, MD

Presentations

1. Pathophysiology of Post-Cardiopulmonary Bypass Vasoplegia
   Faisal Masud, MD,FCCM,FCCP
   Disclosure(s): Astra Zeneca: Advisory Board (Ongoing); La Jolla: Advisory Board (Terminated); Teleflex: Advisory Board (Ongoing)
    
2. An Ounce of Prevention: Steps to Reduce Vasoplegia
   Ravi K. Ghanta, MD
    
3. Efficacy of Methylene Blue & Vitamin B12
   Erica Wittwer, MD, PhD
   Disclosure(s): Pacira Pharmaceuticals: Consultant (Ongoing)
    
4. Steroids in Vasoplegic Shock: Friend or Foe?
   Anna L. Ciullo, MD
    
5. Debate: PRO: Early Initiation of Angiotensin II
   Patrick M. Wieruszewski, PharmD
   Disclosure(s): La Jolla Pharmaceutical Company: Advisory Board (Terminated, November 18, 2021)
    
6. Debate: CON: Early Initiation of Angiotensin II
   Matthew A. Levin, MD
    
7. Putting It All Together: Panel Discussion